Phase 2 trial of linifanib (ABT-869) in patients with advanced renal cell cancer after sunitinib failure.
2011
Purpose
This study assessed the efficacy and safety of linifanib in patients with advanced renal cell carcinoma (RCC) who were previously treated with sunitinib.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
28
References
28
Citations
NaN
KQI